Drug
Nexiguran Ziclumeran
Nexiguran Ziclumeran: highest development phase Phase 3, developed by Intellia Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Intellia Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| nexiguran ziclumeran NCT06672237 | Phase 3 | Neuromuscular Disease |
Latest
No recent events.
Follow Nexiguran Ziclumeran on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.